News
Tata firm, CSIR lab develop Feluda, world’s first CRISPR based COVID-19 test kit
India’s efforts against COVID-19 saw a major fillip when the regulator, Drug Controller General of India (DCGI) gave permission for the commercial launch of India's first Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) COVID-19 test on September 19. The test is names “Feluda'.
Students from UP, Finland win first Biotech Online poster competition organized by Karnataka Government
The Biotech Online poster presentation organized jointly by K-Tech, Association of Biotechnology Led Enterprises (ABLE) and media platform, Biotecnika and Stempeutics, was done completely online in the last week of September.
Dr. Reddy’s signs MoU to receive 100 million doses of Russian Covid Vaccine Sputnik V vaccine
The Russian Direct Investment Fund (RDIF), Russia’s sovereign wealth fund, and ABLE member, Dr. Reddy’s Laboratories Ltd (Dr. Reddy’s) have agreed to cooperate on clinical trials and distribution of Sputnik V vaccine in India.
Serum Institute of India gets DCGI nod to resume clinical trial of Oxford Covid-19 vaccine
SII, which has partnered with AstraZeneca for manufacturing the vaccine candidate for Covid-19, on September 15 submitted the recommendations of the Data and Safety Monitoring Board (DSMB), UK and DSMB, India, and requested for permission to restart enrolment in the clinical trial of the Covid Vaccine.
voice for BT and BEST 2026
